Advertisement

Loading...

MindMaze Therapeutics Holding S.A.

MMTX.SW•SIX
Healthcare
Biotechnology
CHF0.35
CHF0.03(8.02%)
Swiss Market opens in 0h 37m

MindMaze Therapeutics Holding S.A. (MMTX.SW) Stock Overview

Explore MindMaze Therapeutics Holding S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap53.4M
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$-0.01
3 Months$0.00
1 Year Target$0.00

MMTX.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MindMaze Therapeutics Holding S.A. (MMTX.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 25.50, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 53.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
8.02%
5-Day Change
-10.26%
1-Month Change
-50.00%
3-Month Change
-77.42%
6-Month Change
-66.98%
Year-to-Date (YTD) Change
-77.42%
1-Year Change
-66.98%
3-Year Change
-66.98%
5-Year Change
-66.98%
All-Time (Max) Change
-66.98%

Contact Information

https://mindmazetherapeutics.com
41 21 552 08 01
Chemin de Roseneck 5, Lausanne, NaN, 1006

Company Facts

IPO DateDec 15, 2025
CountryCH
Actively Trading

Frequently Asked Questions